Omicron Clouds Novavax’s Delayed COVID-19 Vaccine Debut

After Repeated Delays, Investors Doubt Readiness

 
• By Andrew McConaghie
Novavax
Novavax looks on track to gain an EUA in the US and Europe in early 2022, but may need to develop a new Omicron-targeting version of the vaccine. • Source: Getty Images

More from Business

More from Scrip